Crosstalk between histone/DNA modifications and RNA N6-methyladenosine modification

被引:3
|
作者
Wang, Yushuai [1 ]
Huang, Huilin [2 ]
Chen, Jianjun [3 ,4 ]
Weng, Hengyou [1 ,5 ,6 ]
机构
[1] Guangzhou Natl Lab, Guangzhou 510005, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
[3] Beckman Res Inst City Hope, Dept Syst Biol, Monrovia, CA 91016 USA
[4] Comprehensive Canc Ctr City Hope, Gehr Family Ctr Leukemia Res & City Hope Comprehen, Duarte, CA 91010 USA
[5] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou 510005, Peoples R China
[6] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金; 美国国家卫生研究院;
关键词
GENE-EXPRESSION; N-6-METHYLADENOSINE RNA; M(6)A RNA; STRUCTURAL BASIS; NUCLEAR-RNA; METHYLATION; CHROMATIN; METABOLISM; RECOGNITION; TRANSLATION;
D O I
10.1016/j.gde.2024.102205
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
N6-methyladenosine 6-methyladenosine (m6A) 6 A) is the most prevalent internal RNA modification in eukaryotic messenger RNAs (mRNAs), regulating gene expression at the transcription and post- transcription levels. Complex interplay between m6A 6 A and other well-studied epigenetic modifications, including histone modifications and DNA modification, has been extensively reported in recent years. The crosstalk between RNA m6A 6 A modification and histone/DNA modifications plays a critical role in establishing the chromatin state for the precise and specific fine-tuning of gene expression and undoubtedly has profound impacts on both physiological and pathological processes. In this review, we discuss the crosstalk between RNA m6A 6 A modification and histone/DNA modifications, emphasizing their sophisticated communications and the mechanisms underlying to gain a comprehensive view of the biological relevance of m6A-based 6 A-based epigenetic network.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Mechanism of RNA modification N6-methyladenosine in human cancer
    Zhou, Zijian
    Lv, Jiancheng
    Yu, Hao
    Han, Jie
    Yang, Xiao
    Feng, Dexiang
    Wu, Qikai
    Yuan, Baorui
    Lu, Qiang
    Yang, Haiwei
    MOLECULAR CANCER, 2020, 19 (01)
  • [32] N6-Methyladenosine Modification Controls Circular RNA Immunity
    Chen, Y. Grace
    Chen, Robert
    Ahmad, Sadeem
    Verma, Rohit
    Kasturi, Sudhir Pai
    Amaya, Laura
    Broughton, James P.
    Kim, Jeewon
    Cadena, Cristhian
    Pulendran, Bali
    Hur, Sun
    Chang, Howard Y.
    MOLECULAR CELL, 2019, 76 (01) : 96 - +
  • [33] The role of N6-methyladenosine RNA modification in platinum resistance
    Wang, Kai
    Wang, Lingfang
    Chen, Xiaojing
    Gu, Jiaxin
    Cheng, Xiaodong
    EPIGENOMICS, 2023, 15 (22) : 1221 - 1232
  • [34] Functions of RNA N6-methyladenosine modification in cancer progression
    Bing Chen
    Ya Li
    Ruifeng Song
    Chen Xue
    Feng Xu
    Molecular Biology Reports, 2019, 46 : 1383 - 1391
  • [35] Immune dysregulation and RNA N6-methyladenosine modification in sepsis
    Chen, Hongyan
    Zhang, Xiaoting
    Su, Hao
    Zeng, Judeng
    Chan, Hung
    Li, Qing
    Liu, Xiaodong
    Zhang, Lin
    Wu, William Ka Kei
    Chan, Matthew Tak Vai
    Chen, Huarong
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2023, 14 (03)
  • [36] The N6-methyladenosine RNA modification in acute myeloid leukemia
    Yankova, Eliza
    Aspris, Demetrios
    Tzelepis, Konstantinos
    CURRENT OPINION IN HEMATOLOGY, 2021, 28 (02) : 80 - 85
  • [37] RNA N6-Methyladenosine Modification in Normal and Malignant Hematopoiesis
    Weng, Hengyou
    Huang, Huilin
    Chen, Jianjun
    LEUKEMIA STEM CELLS IN HEMATOLOGIC MALIGNANCIES, 2019, 1143 : 75 - 93
  • [38] Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions
    Xin Wang
    Rui Ma
    Xilin Zhang
    Lian Cui
    Yangfeng Ding
    Weimin Shi
    Chunyuan Guo
    Yuling Shi
    Molecular Cancer, 20
  • [39] Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions
    Wang, Xin
    Ma, Rui
    Zhang, Xilin
    Cui, Lian
    Ding, Yangfeng
    Shi, Weimin
    Guo, Chunyuan
    Shi, Yuling
    MOLECULAR CANCER, 2021, 20 (01)
  • [40] The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
    Xiaoxin Xu
    Jiayao Zhao
    Mingyue Yang
    Lutuo Han
    Xingxing Yuan
    Wencheng Chi
    Jiakang Jiang
    European Journal of Medical Research, 28